Musalos 15 Mg & 30 Mg 15 mg, 30 mg Capsule
PDF Leaflet Revision Date: 16 August 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Management of obesity as an adjunct to a weight reduction regimen.
Dosage (summary)
One capsule daily at 7 a.m.; avoid evening doses.
Special Populations
- Elderly
- Diabetic patients
- Epileptic patients
- Patients with hypertension
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation due to safety concerns.
Key Drug Interactions
- Monoamine Oxidase Inhibitors
- Sympathomimetic medicines
- Selective serotonin reuptake inhibitors
- Alcohol
Contraindications
- Hypersensitivity to phentermine
- Pulmonary artery hypertension
- Cardiac disease
- Hyperthyroidism
- Glaucoma
- History of drug/alcohol abuse
- Obstructive uropathy
- Poorly controlled epilepsy
Common side effects
- Insomnia
- Nervousness
- Tachycardia
- Hypertension
- Nausea
Counselling Points
- Take in the morning
- Avoid alcohol
- Report any severe side effects
- Do not exceed recommended dose
Serious warnings
- Primary pulmonary hypertension
- Cardiac valvular disease
- Cerebrovascular accidents
Important Disclaimer
The Musalos 15 Mg & 30 Mg 15 mg, 30 mg Capsule professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
